Gujarat Kidney

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: INE0V0W01025
  • NSEID: GKSL
  • BSEID: 544666
INR
148.60
-1.85 (-1.23%)
BSENSE

Nov 20

BSE+NSE Vol: 7.32 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

7.32 lacs (22.52%) Volume

Shareholding (Sep 2026)

FII

6.53%

Held by 10 FIIs

DII

0.26%

Held by 1 DIIs

Promoter

71.45%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor Management Efficiency with a low ROCE of 9.93%

  • The company has been able to generate a Return on Capital Employed (avg) of 9.93% signifying low profitability per unit of total capital (equity and debt)
2

With a growth in Net Sales of 194.59%, the company declared Outstanding results in Sep 26

3

With ROE of 7.2, it has a Very Expensive valuation with a 4.4 Price to Book Value

 
4

Increasing Participation by Institutional Investors

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

INR 1,198 Cr (Micro Cap)

stock-summary
P/E

62.00

stock-summary
Industry P/E

63

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

7.21%

stock-summary
Price to Book

4.51

Revenue and Profits:
Net Sales:
38 Cr
(Quarterly Results - Sep 2026)
Net Profit:
6 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.35%
0%
-5.35%
6 Months
5.54%
0%
5.54%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Gujarat Kidney for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

Gujarat Kidney & Super Speciality Ltd Falls 4.84%: Mixed Signals Shape Weekly Decline

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

11-Nov-2026 | Source : BSE

Transcript of Earning Call conducted on 05/11/2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

05-Nov-2026 | Source : BSE

Audio recording of earning call

Announcement under Regulation 30 (LODR)-Newspaper Publication

05-Nov-2026 | Source : BSE

Newspaper publication for Unaudited Financial Statements for the Quarter ended September 2026.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
103.80%
EBIT Growth (5y)
67.85%
EBIT to Interest (avg)
13.40
Debt to EBITDA (avg)
0.97
Net Debt to Equity (avg)
-0.01
Sales to Capital Employed (avg)
0.63
Tax Ratio
19.17%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.78%
ROCE (avg)
21.96%
ROE (avg)
7.21%
Valuation key factors
Factor
Value
P/E Ratio
62
Industry P/E
63
Price to Book Value
4.44
EV to EBIT
44.99
EV to EBITDA
36.78
EV to Capital Employed
4.47
EV to Sales
9.27
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.93%
ROE (Latest)
7.21%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
Bollinger Bands
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 10 FIIs (6.53%)

Promoter with highest holding

Pragnesh Yashwantsinh Bharpoda (38.16%)

Highest Public shareholder

Goldman Sachs Investments (mauritius) I Ltd (3.5%)

Individual Investors Holdings

9.51%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2026 is 11.08% vs 12.13% in Jun 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2026 is 12.74% vs 2.78% in Jun 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'26",
        "Jun'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "38.09",
          "val2": "34.29",
          "chgp": "11.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.22",
          "val2": "8.38",
          "chgp": "21.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.66",
          "val2": "0.66",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.84",
          "val2": "5.18",
          "chgp": "12.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.83%",
          "val2": "24.44%",
          "chgp": "2.39%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Gujarat Kidney"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Gujarat Kidney"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40.10",
          "val2": "35.17",
          "chgp": "14.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.14",
          "val2": "15.45",
          "chgp": "4.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.15",
          "val2": "0.53",
          "chgp": "116.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.90",
          "val2": "9.11",
          "chgp": "8.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.25%",
          "val2": "43.93%",
          "chgp": "-3.68%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQstock-summary
Sep'26
Jun'26
Change(%)
Net Sales
38.09
34.29
11.08%
Operating Profit (PBDIT) excl Other Income
10.22
8.38
21.96%
Interest
0.66
0.66
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.84
5.18
12.74%
Operating Profit Margin (Excl OI)
26.83%
24.44%
2.39%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2026 is 11.08% vs 12.13% in Jun 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2026 is 12.74% vs 2.78% in Jun 2026

Annual Results Snapshot (Standalone) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
40.10
35.17
14.02%
Operating Profit (PBDIT) excl Other Income
16.14
15.45
4.47%
Interest
1.15
0.53
116.98%
Exceptional Items
0.00
0.00
Standalone Net Profit
9.90
9.11
8.67%
Operating Profit Margin (Excl OI)
40.25%
43.93%
-3.68%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details